Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec;7(6):1214-22.
doi: 10.1161/CIRCEP.114.001973. Epub 2014 Nov 11.

Loss of microRNA-106b-25 cluster promotes atrial fibrillation by enhancing ryanodine receptor type-2 expression and calcium release

Affiliations

Loss of microRNA-106b-25 cluster promotes atrial fibrillation by enhancing ryanodine receptor type-2 expression and calcium release

David Y Chiang et al. Circ Arrhythm Electrophysiol. 2014 Dec.

Abstract

Background: Enhanced sarcoplasmic reticulum Ca(2+)-leak via ryanodine receptor type-2 (RyR2) contributes to the pathogenesis of atrial fibrillation (AF). Recent studies have shown that the level of RyR2 protein is elevated in atria of patients with paroxysmal AF, suggesting that microRNA-mediated post-transcriptional regulation of RyR2 might be an underlying mechanism. Bioinformatic analysis suggests that miR-106b and miR-93, members of the miR-106b-25 cluster, could bind to RyR2-3'-untranslated region and suppress its translation. Thus, we tested the hypothesis that loss of the miR-106b-25 cluster promotes AF via enhanced RyR2-mediated sarcoplasmic reticulum Ca(2+)-leak.

Methods and results: Quantitative real-time polymerase chain reaction showed that the levels of mature miR-106b, miR-93, and miR-25 were lower in atria of patients with paroxysmal AF when compared with patients in sinus rhythm. In vitro assay showed that miR-93 reduced RyR2-3'-untranslated region luciferase activity. Total RyR2 protein in atrial tissue of miR-106b-25(-/-) mice was increased by 42% when compared with wild-type littermates but still maintained a normal subcellular distribution. Ca(2+)-spark frequency and total sarcoplasmic reticulum Ca(2+)-leak were increased in atrial myocytes of miR-106b-25(-/-) mice. Telemetry ECG recordings revealed that miR-106b-25(-/-) mice exhibited more frequent atrial ectopy and were also more susceptible to pacing-induced AF than wild-type littermates. Increased sarcoplasmic reticulum Ca(2+)-release and AF susceptibility in miR-106b-25(-/-) mice were abolished by the RyR2 blocker K201.

Conclusions: These results suggest that miR-106b-25 cluster-mediated post-transcriptional regulation of RyR2 is a potential molecular mechanism involved in paroxysmal AF pathogenesis. As such, the miR-106b-25 cluster could be a novel gene-therapy target in AF associated with enhanced RyR2 expression.

Keywords: atrial fibrillation; microRNA; ryanodine receptor calcium release channel.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: X.H.T.W. is a founding partner of Elex Biotech, a company that develops new drugs targeting intracellular calcium leak.

Figures

Figure 1
Figure 1
Upregulation of RyR2 and downregulation of the miR-106b-25 cluster in pAF patients. A) WB analysis revealed increased RyR2 protein levels in sarcoplasmic reticulum preparation of atrial biopsies from patients with pAF versus control patients in SNR. B) qRT-PCR showing unchanged levels of RYR2 mRNA in atrial samples of pAF patients. C) qRT-PCR showing downregulation of the miR-106b-25 cluster and miR-106a in pAF patients. Numbers in bars indicate number of patients. *P<0.05, **P<0.01 vs. SNR.
Figure 2
Figure 2
miR-93 target RYR2-3′UTR. A) Sequences of mature miR-106b, miR-93, miR-25, and miR-106a. B) Predicted interaction between human (h) Ryr2-3′UTR and miR-93 (i) and mutation of the binding site (ii). C) Predicted interaction between mouse (m) Ryr2-3′UTR and miR-93 (i) and mutation of the binding site (ii). D) Dual luciferase assay of 3′UTR constructs in the presence of scramble, miR-106b, miR-93, miR-25, and miR-106a mimics. n=4 or 8 per group. **P<0.01.
Figure 3
Figure 3
Increased RyR2 protein levels in miR-106b-25−/− atria. A) qRT-PCR showing unchanged levels of Ryr2 mRNA in miR-106b-25−/− atria. B) Representative western blots and dot plot showing upregulated RyR2 protein levels in miR-106b-25−/− atrial lysates. *P<0.05. C) Representative western blots and bar graph showing unchanged expression of other major Ca2+-handling proteins and phosphorylation of RyR2 at serine (S)2814 in miR-106b-25−/− atria. N=3–4 animals per group.
Figure 4
Figure 4
Enhanced RyR2 Ca2+-release activity in miR-106b-25−/− atrial myocytes. A) Representative line-scan images of Ca2+-spark recordings in isolated atrial myocytes. B) Bar graph showing increased CaSF normalized to SR load in miR-106b-25−/− atrial myocytes, normalized by K201. C) Bar graph showing unchanged Ca2+-spark amplitude comparing miR-106b-25−/− and WT atrial myocytes. D) Bar graph showing an increase in the FWHM of Ca2+-sparks in miR-106b-25−/− atrial myocytes, normalized by RyR2 blocker K201. Numbers inside bars indicate number of cells studied from 3 mice per group. *P<0.05, **P<0.01, ***P<0.001.
Figure 5
Figure 5
Enhanced SR Ca2+-leak and arrhythmogenic Ca2+-release in miR-106b-25−/− atrial myocytes. A) Representative SR Ca2+-leak measurements in atrial myocytes. NT=normal Tyrode solution; TTC=tetracaine. B) Bar graph showing increased relative levels of SR Ca2+-leak in miR-106b-25−/− atrial myocytes. Representative tracing (C) and summary bar graph (D) showing increased spontaneous Ca2+-wave frequency in high Ca2+-buffer with isoproterenol in atrial myocytes from miR-106b-25−/− versus WT littermates (n=3–4 mice per group). Red arrow marks a spontaneous Ca2+-wave. Numbers inside bars indicate number of cells studied. *P<0.05, **P<0.01.
Figure 6
Figure 6
miR-106b-25 deficiency leads to increased atrial ectopy and atrial weight. A) Representative ECG telemetry recordings and B) dot plot showing premature atrial contractions (PACs) per hour in miR-106b-25−/− mice. C) Representative whole mount photographs and atrial weight normalized to tibial length (AW/TL; D) showing enlarged atria in miR-106b-25−/− mice. **P<0.01 vs WT.
Figure 7
Figure 7
miR-106b-25 deficiency leads to enhanced AF susceptibility. Representative recordings of surface ECG and intracardiac electrograms in WT (A), miR-106b-25−/− (B), and miR-106b-25−/− mice treated with RyR2 blocker K201 (C). D) Bar graph summarizing the incidence of pacing-induced AF showing an increase in miR-106b-25−/− mice, suppressed by K201. Numbers inside bars indicate numbers of mice studied. *P<0.05.

Similar articles

Cited by

References

    1. Nattel S. Experimental evidence for proarrhythmic mechanisms of antiarrhythmic drugs. Cardiovasc Res. 1998;37:567–577. - PubMed
    1. Li N, Chiang DY, Wang S, Wang Q, Sun L, Voigt N, Respress JL, Ather S, Skapura DG, Jordan VK, Horrigan FT, Schmitz W, Muller FU, Valderrabano M, Nattel S, Dobrev D, Wehrens XH. Ryanodine receptor-mediated calcium leak drives progressive development of an atrial fibrillation substrate in a transgenic mouse model. Circulation. 2014;129:1276–1285. - PMC - PubMed
    1. Chiang DY, Li N, Wang Q, Alsina KM, Quick AP, Reynolds JO, Wang G, Skapura D, Voigt N, Dobrev D, Wehrens XH. Impaired local regulation of ryanodine receptor type 2 by protein phosphatase 1 promotes atrial fibrillation. Cardiovasc Res. 2014;103:178–187. - PMC - PubMed
    1. Voigt N, Heijman J, Wang Q, Chiang DY, Li N, Karck M, Wehrens XH, Nattel S, Dobrev D. Cellular and molecular mechanisms of atrial arrhythmogenesis in patients with paroxysmal atrial fibrillation. Circulation. 2013;129:145–156. - PMC - PubMed
    1. Chelu MG, Sarma S, Sood S, Wang S, van Oort RJ, Skapura DG, Li N, Santonastasi M, Muller FU, Schmitz W, Schotten U, Anderson ME, Valderrabano M, Dobrev D, Wehrens XH. Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice. J Clin Invest. 2009;119:1940–1951. - PMC - PubMed

Publication types

MeSH terms